308 related articles for article (PubMed ID: 19188662)
41. Immunological complications of blood transfusions.
Brand A
Presse Med; 2016; 45(7-8 Pt 2):e313-24. PubMed ID: 27499223
[TBL] [Abstract][Full Text] [Related]
42. Autologous transfusion and other approaches to reduce allogeneic blood exposure.
Vamvakas EC; Pineda AA
Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):533-47. PubMed ID: 11102275
[TBL] [Abstract][Full Text] [Related]
43. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
[TBL] [Abstract][Full Text] [Related]
44. Future preventive and therapeutic targets for transfusion-related acute lung injury.
Curtis BR
Curr Pharm Des; 2012; 18(22):3285-92. PubMed ID: 22621267
[TBL] [Abstract][Full Text] [Related]
45. [Update on infectious risks associated with blood products].
Traineau R; Elghouzzi MH; Bierling P
Rev Prat; 2009 Jan; 59(1):86-9. PubMed ID: 19253889
[TBL] [Abstract][Full Text] [Related]
46. Donor characteristics do not influence transfusion-related acute lung injury incidence in a secondary analysis of two case-control studies.
Peters AL; van de Weerdt EK; Prinsze F; de Korte D; Juffermans NP; Vlaar APJ
Transfus Clin Biol; 2019 Feb; 26(1):10-17. PubMed ID: 30686333
[TBL] [Abstract][Full Text] [Related]
47. Transfusion-related acute lung injury: Current understanding and preventive strategies.
Vlaar AP
Transfus Clin Biol; 2012 Jun; 19(3):117-24. PubMed ID: 22682310
[TBL] [Abstract][Full Text] [Related]
48. Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty.
Innerhofer P; Klingler A; Klimmer C; Fries D; Nussbaumer W
Transfusion; 2005 Jan; 45(1):103-10. PubMed ID: 15647025
[TBL] [Abstract][Full Text] [Related]
49. Transfusion-related acute lung injury: report of a clinical look-back investigation.
Kopko PM; Marshall CS; MacKenzie MR; Holland PV; Popovsky MA
JAMA; 2002 Apr; 287(15):1968-71. PubMed ID: 11960539
[TBL] [Abstract][Full Text] [Related]
50. How clinicians can minimize transfusion-related adverse events?
Aubron C; Aries P; Le Niger C; Sparrow RL; Ozier Y
Transfus Clin Biol; 2018 Nov; 25(4):257-261. PubMed ID: 30197000
[TBL] [Abstract][Full Text] [Related]
51. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion.
Bux J
Vox Sang; 2005 Jul; 89(1):1-10. PubMed ID: 15938734
[TBL] [Abstract][Full Text] [Related]
52. Noninfectious transfusion-associated adverse events and their mitigation strategies.
Goel R; Tobian AAR; Shaz BH
Blood; 2019 Apr; 133(17):1831-1839. PubMed ID: 30808635
[TBL] [Abstract][Full Text] [Related]
53. Benefit of transfusion-related acute lung injury risk-minimization measures--German haemovigilance data (2006-2010).
Funk MB; Guenay S; Lohmann A; Henseler O; Heiden M; Hanschmann KM; Keller-Stanislawski B
Vox Sang; 2012 May; 102(4):317-23. PubMed ID: 21967322
[TBL] [Abstract][Full Text] [Related]
54. Update on pathogen reduction technology for therapeutic plasma: an overview.
Solheim BG; Seghatchian J
Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
[TBL] [Abstract][Full Text] [Related]
55. Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma.
Berséus O; Boman K; Nessen SC; Westerberg LA
Transfusion; 2013 Jan; 53 Suppl 1():114S-123S. PubMed ID: 23301963
[TBL] [Abstract][Full Text] [Related]
56. Allogeneic blood transfusion in bilateral lung transplantation: impact on early function and mortality.
Ong LP; Thompson E; Sachdeva A; Ramesh BC; Muse H; Wallace K; Parry G; Clark SC
Eur J Cardiothorac Surg; 2016 Feb; 49(2):668-74; discussion 674. PubMed ID: 25913825
[TBL] [Abstract][Full Text] [Related]
57. Blood donor and component management strategies to prevent transfusion-related acute lung injury (TRALI).
Mair DC; Hirschler N; Eastlund T
Crit Care Med; 2006 May; 34(5 Suppl):S137-43. PubMed ID: 16617258
[TBL] [Abstract][Full Text] [Related]
58. Number needed to treat and cost of recombinant human erythropoietin to avoid one transfusion-related adverse event in critically ill patients.
Shermock KM; Horn E; Lipsett PA; Pronovost PJ; Dorman T
Crit Care Med; 2005 Mar; 33(3):497-503. PubMed ID: 15753738
[TBL] [Abstract][Full Text] [Related]
59. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine.
Hillyer CD; Josephson CD; Blajchman MA; Vostal JG; Epstein JS; Goodman JL
Hematology Am Soc Hematol Educ Program; 2003; ():575-89. PubMed ID: 14633800
[TBL] [Abstract][Full Text] [Related]
60. Transfusion-related acute lung injury (TRALI).
Roberts GH
Clin Lab Sci; 2004; 17(3):133-5. PubMed ID: 15314887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
